SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-135938
Filing Date
2008-06-18
Accepted
2008-06-18 16:08:44
Documents
15
Period of Report
2008-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 35403
2 SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 189296
3 REGISTRATION RIGHTS AGREEMENT dex102.htm EX-10.2 109865
4 8% ORIGINAL ISSUE DISCOUNT SECURED CONVERTIBLE DEBENTURE dex103.htm EX-10.3 134397
5 SECURITY AGREEMENT dex104.htm EX-10.4 117300
6 COMMON STOCK PURCHASE WARRANT dex105.htm EX-10.5 79370
7 SUBSIDIARY GUARANTEE dex106.htm EX-10.6 58360
8 THIRD AMENDMENT TO REVOLVING CREDIT AGREEMENT dex107.htm EX-10.7 14947
9 REVOLVING CREDIT NOTE MODIFICATION AGREEMENT dex108.htm EX-10.8 9094
10 STOCK PLEDGE AGREEMENT dex109.htm EX-10.9 27802
11 REAFFIRMATION OF GUARANTY dex1010.htm EX-10.10 29832
12 AMENDMENT NO.1 TO TERMINATION AGREEMENT dex1011.htm EX-10.11 37649
13 STOCK PLEDGE AGREEMENT dex1012.htm EX-10.12 61584
14 PRESS RELEASE dex991.htm EX-99.1 10123
15 GRAPHIC g30179image001.jpg GRAPHIC 23042
  Complete submission text file 0001193125-08-135938.txt   948653
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 000-51383 | Film No.: 08905795
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1